Bilal Omer, MD

“Engineering more potent T cells to target lymphoma associated antigens”

We have developed strategies to grow a patient’s own immune cells in the laboratory and then re-inject them into the patient to fight lymphoma. In a clinical trial at our center, 3 of 7 patients with active lymphoma responded to this treatment without the need for chemotherapy. Dr. Omer’s research will now plan to genetically modify these immune cells to make them more powerful.